Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Netherlands,Czech Republic,Poland,Hungary,Spain,Finland,Russian Federation,France,Slovakia,Sweden,Portugal
nct
Update Il y a 5 ans
A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids
The purpose of this study is to focus on potential differences in the occurrence of new-onset Diabetes Mellitus (a glucose metabolism disorder) when two different regimens of immunosuppressive treatment are compared.
Country
Australia
,
Belgium
,
Colombia
,
Czech Republic
,
Estonia
,
Finland
,
France
,
Germany
,
Hungary
,
Italy
,
Korea, Republic of
,
Latvia
,
Lithuania
,
Mexico
,
Netherlands
,
Norway
,
Poland
,
Portugal
,
Romania
,
Russian Federation
,
Slovakia
,
Spain
,
Sweden
,
Switzerland
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death
The Primary objective was to assess the efficacy of Celivarone for the prevention of Implantable Cardioverter Defibrillator (ICD) interventions or death. Secondary objectives were: - To assess the tolerability and safety of the different dose regimens of Celivarone in the selected population. - To document Celivarone plasma levels during the study.
Country
Argentina
,
Australia
,
Belgium
,
Canada
,
Chile
,
Czech Republic
,
Denmark
,
Finland
,
France
,
Germany
,
Hungary
,
Israel
,
Italy
,
Japan
,
Mexico
,
Netherlands
,
Norway
,
Poland
,
Portugal
,
Russian Federation
,
Slovakia
,
South Africa
,
Spain
,
Sweden
,
Turkey
,
United States
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Crestor Versus Placebo in Subjects With Heart Failure
The purpose of the study is to investigate if rosuvastatin, added on top of all other medicines prescribed to subjects with symptomatic systolic heart failure, reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction or non-fatal stroke (time to first event)
Country
Belgium
,
Bulgaria
,
Czech Republic
,
Denmark
,
Finland
,
France
,
Germany
,
Hungary
,
Ireland
,
Netherlands
,
Norway
,
Poland
,
Portugal
,
Romania
,
Russian Federation
,
Slovakia
,
South Africa
,
Spain
,
Sweden
,
Switzerland
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
1